Endothelin-A Receptor Antagonism Reduces Blood Pressure and Increases Renal Blood Flow in Hypertensive Patients With Chronic Renal Failure-Reference-Cited by-同舟云学术

Endothelin-A Receptor Antagonism Reduces Blood Pressure and Increases Renal Blood Flow in Hypertensive Patients With Chronic Renal Failure

Published:2004-03-09 Issue:9 Volume:109 Page:1186-1193
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Goddard Jane¹,Johnston Neil R.¹,Hand Malcolm F.¹,Cumming Allan D.¹,Rabelink Ton J.¹,Rankin Andrew J.¹,Webb David J.¹

Affiliation:

1. From the Centre for Cardiovascular Science (J.G., N.R.J., A.D.C., D.J.W.), University of Edinburgh, Edinburgh, United Kingdom; Monklands Hospital (M.F.H.), Airdrie, Lanarkshire, United Kingdom; Department of Nephrology & Hypertension (T.J.R.), University Hospital, Utrecht, Netherlands; and Pfizer Global Research & Development (A.J.R.), Sandwich, United Kingdom.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Cloning and expression of a cDNA encoding an endothelin receptor

2. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor

3. Venous smooth muscle contains vasoconstrictor ETB-like receptors

4. The endothelin system and its potential as a therapeutic target in cardiovascular disease

5. Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETBreceptors

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kidney Dysfunction, Hepatic Impairment, and Lipid Metabolism Abnormalities in Patients with Precapillary Pulmonary Hypertension;Diagnostics;2024-08-21

2. Mechanism of protective actions of sparsentan in the kidney: lessons from studies in models of chronic kidney disease;Clinical Science;2024-05-29

3. Endothelin receptor antagonists in diabetic and non-diabetic chronic kidney disease;Clinical Kidney Journal;2024-03-19

4. New Drugs Under Development for Cardiovascular Prevention;Early Vascular Aging (EVA);2024

5. Pathomechanisms of Diabetic Kidney Disease;Journal of Clinical Medicine;2023-11-27